Stock Research: Medicover

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Medicover

OM:MCOV B SE0009778848
46
  • Value
    26
  • Growth
    99
  • Safety
    Safety
    10
  • Combined
    35
  • Sentiment
    62
  • 360° View
    360° View
    46
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Medicover AB is a Sweden-based healthcare and diagnostic services provider. It offers healthcare services (primary care, specialist outpatient and inpatient care via clinics and medical facilities) and diagnostic services (laboratory testing for humans and some veterinary services). The company primarily operates in Poland, Germany, Romania, and Ukraine. In the last fiscal year, the company had a market cap of $4085 million, profits of $464 million, revenue of $2166 million, and 47256 employees.

more
Index
Human Rights
SDG 13
SDG 16
SDG 3
SDG 4
SDG 8
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
26 34 28 29
Growth
99 98 100 87
Safety
Safety
10 9 14 42
Sentiment
62 42 42 41
360° View
360° View
46 39 41 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
48 51 41 43
Opinions Change
50 50 83 50
Pro Holdings
n/a 24 4 30
Market Pulse
62 49 59 56
Sentiment
62 42 42 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
26 34 28 29
Growth
99 98 100 87
Safety Safety
10 9 14 42
Combined
35 34 41 56
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
16 17 10 13
Price vs. Earnings (P/E)
77 75 73 64
Price vs. Book (P/B)
12 16 22 18
Dividend Yield
43 45 47 48
Value
26 34 28 29
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
90 85 94 84
Profit Growth
100 88 71 96
Capital Growth
98 68 93 6
Stock Returns
57 90 57 97
Growth
99 98 100 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
4 5 16 46
Refinancing
17 16 15 37
Liquidity
22 24 24 30
Safety Safety
10 9 14 42

Similar Stocks

Discover high‑ranked alternatives to Medicover and broaden your portfolio horizons.

BMW

XTRA:BMW
Country: Germany
Industry: Automobile Manufacturers
Size: XX-Large
Full Stock Analysis

Repsol

BME:REP
Country: Spain
Industry: Oil & Gas Integrated
Size: X-Large
Full Stock Analysis

Drägerwerk

XTRA:DRW3
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Prosus

ENXTAM:PRX
Country: Netherlands
Industry: Internet Retail
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: